Sign up to save your podcasts
Or
Share How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo
Welcome back to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain dive into the world of diffused large B-cell lymphoma with special guest Dr. Carla Casulo from the Wilmot Cancer Institute in Rochester, New York.
Key Points Covered:
• Understanding the importance of accurate diagnosis through excisional biopsy in diffused large B-cell lymphoma.
• Exploring the significance of cell of origin in guiding treatment decisions.
• Initial treatment approaches for stage 1 and 2 disease, including the use of Polatuzumab based on the POLARIX trial.
• Treatment options for relapsed or refractory disease, including CAR-T therapy, BiTE therapy, and anti-CD19 antibody agents.
• Managing toxicities associated with different treatment regimens, such as cytopenias, infections, and neurotoxicity.
Join us as we unravel the complexities of diffused large B-cell lymphoma and discuss the latest advancements in treatment options with Dr. Carla Casulo. Stay informed and up to date with the Oncology Brothers podcast!
Don't forget to like, share, and subscribe for more insightful discussions on oncology topics. Thank you for tuning in to the Oncology Brothers podcast.
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at [email protected]
View all episodes
By Oncology Brothers
4.8
3939 ratings
Welcome back to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain dive into the world of diffused large B-cell lymphoma with special guest Dr. Carla Casulo from the Wilmot Cancer Institute in Rochester, New York.
Key Points Covered:
• Understanding the importance of accurate diagnosis through excisional biopsy in diffused large B-cell lymphoma.
• Exploring the significance of cell of origin in guiding treatment decisions.
• Initial treatment approaches for stage 1 and 2 disease, including the use of Polatuzumab based on the POLARIX trial.
• Treatment options for relapsed or refractory disease, including CAR-T therapy, BiTE therapy, and anti-CD19 antibody agents.
• Managing toxicities associated with different treatment regimens, such as cytopenias, infections, and neurotoxicity.
Join us as we unravel the complexities of diffused large B-cell lymphoma and discuss the latest advancements in treatment options with Dr. Carla Casulo. Stay informed and up to date with the Oncology Brothers podcast!
Don't forget to like, share, and subscribe for more insightful discussions on oncology topics. Thank you for tuning in to the Oncology Brothers podcast.
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at [email protected]
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
NEJM This Week
322 Listeners
Journal of Clinical Oncology (JCO) Podcast
42 Listeners
Research To Practice | Oncology Videos
111 Listeners
JAMA Clinical Reviews
504 Listeners
ASCO Daily News
60 Listeners
Core IM | Internal Medicine Podcast
1,114 Listeners
OncoPharm
182 Listeners
ASCO Guidelines
45 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
360 Listeners
Lung Cancer Considered
28 Listeners
The Passive Income MD Podcast
277 Listeners
Oncology Today with Dr Neil Love
60 Listeners
Two Onc Docs
181 Listeners
Blood Cancer Talks
48 Listeners